Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Repurchased

Daily Values

Growth Metrics

Others

Genworth Financial (GNW) Amortization of Goodwill (2020)

Genworth Financial filings provide 2 years of Amortization of Goodwill readings, the most recent being $3.0 million for Q2 2020.

Quarterly Amortization of Goodwill changed N/A to $3.0 million in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2020, down 97.93% year-over-year, with the annual reading at $5.0 million for FY2020, N/A changed from the prior year.
Amortization of Goodwill hit $3.0 million in Q2 2020 for Genworth Financial, down from $145.0 million in the prior quarter.
Across five years, Amortization of Goodwill topped out at $3.0 million in Q2 2020 and bottomed at $3.0 million in Q2 2020.